Dose reduction is a feasible strategy in patients with plaque psoriasis who achieve sustained response with secukinumab: a retrospective, multicenter cohort study in daily practice setting

1. Daudén, E.
2. Escario, E.
3. Martos-Cabrera, L.
4. Armesto, S.
5. Herrera-Acosta, E.
6. Vidal, D.
7. Vilarrasa, E.
8. Rivera, R.
9. de la Cueva, P.
10. Martorell, A.
11. Ballesca, F.
12. Belinchón, I.
13. Carretero, G.
14. Rodríguez, L.
15. Romero-Maté, A.
16. Pujol-Montcusí, J.
17. Salgado, L.
18. Sahuquillo-Torralba, A.
19. Coto-Segura, P.
20. Baniandrés, O.
21. Feltes, R.
22. Riera-Monroig, J.
23. Garrido, J.
24. Llamas-Velasco, M.